New Sickle-Cell Clinic Opens on Chicago's South Side Amid Long-Delayed Launch
A major milestone has finally been reached in addressing a long-standing health disparity on Chicago's South Side. The Roseland Community Hospital, primarily serving African American patients, has opened a dedicated sickle-cell treatment clinic – six years after its initial projected launch.
The new clinic, which began operations Monday morning, will provide much-needed care for patients suffering from the debilitating blood disorder that disproportionately affects African Americans. Sickle cell disease can cause excruciating pain and organ damage, often requiring emergency department visits during crisis situations. However, untrained healthcare providers may misinterpret sickle-cell patients as drug seekers or doubt their condition's severity, leading to prolonged waits for treatment.
According to Dr. Khurram Khan, Roseland Community Hospital's Chief Medical Officer, the new clinic will offer immediate care for patients experiencing a sickle-cell pain crisis, addressing a critical gap in treatment options. By having a board-certified hematologist-oncologist, Dr. Mahoud Mahafzah, on staff, the clinic can provide specialized care that is not typically available in emergency departments or general wards.
The clinic's initial offerings include hydration therapy, IV pain management for vaso-occlusive crises, blood transfusions, chelation therapy for chronic iron overload, and comprehensive patient education. Khan emphasized that this specialized care will enable patients to receive the necessary treatment without having to visit the ER, ultimately reducing the need for emergency room visits.
The clinic's delayed launch has been attributed to various challenges, including the COVID-19 pandemic and recruitment difficulties for medical staff, particularly a board-certified hematologist-oncologist. CEO Tim Egan initially envisioned the clinic's opening in 2019, but obstacles have continued to hinder its progress.
While the new sickle-cell clinic is a welcome development on Chicago's South Side, it highlights the need for increased investment and attention to addressing health disparities affecting African American communities.
A major milestone has finally been reached in addressing a long-standing health disparity on Chicago's South Side. The Roseland Community Hospital, primarily serving African American patients, has opened a dedicated sickle-cell treatment clinic – six years after its initial projected launch.
The new clinic, which began operations Monday morning, will provide much-needed care for patients suffering from the debilitating blood disorder that disproportionately affects African Americans. Sickle cell disease can cause excruciating pain and organ damage, often requiring emergency department visits during crisis situations. However, untrained healthcare providers may misinterpret sickle-cell patients as drug seekers or doubt their condition's severity, leading to prolonged waits for treatment.
According to Dr. Khurram Khan, Roseland Community Hospital's Chief Medical Officer, the new clinic will offer immediate care for patients experiencing a sickle-cell pain crisis, addressing a critical gap in treatment options. By having a board-certified hematologist-oncologist, Dr. Mahoud Mahafzah, on staff, the clinic can provide specialized care that is not typically available in emergency departments or general wards.
The clinic's initial offerings include hydration therapy, IV pain management for vaso-occlusive crises, blood transfusions, chelation therapy for chronic iron overload, and comprehensive patient education. Khan emphasized that this specialized care will enable patients to receive the necessary treatment without having to visit the ER, ultimately reducing the need for emergency room visits.
The clinic's delayed launch has been attributed to various challenges, including the COVID-19 pandemic and recruitment difficulties for medical staff, particularly a board-certified hematologist-oncologist. CEO Tim Egan initially envisioned the clinic's opening in 2019, but obstacles have continued to hinder its progress.
While the new sickle-cell clinic is a welcome development on Chicago's South Side, it highlights the need for increased investment and attention to addressing health disparities affecting African American communities.